Viewing Study NCT05333159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:45 PM
Ignite Modification Date: 2026-02-02 @ 10:53 PM
Study NCT ID: NCT05333159
Status: UNKNOWN
Last Update Posted: 2022-04-18
First Post: 2022-04-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.
Sponsor: Beijing Anzhen Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronary Artery Disease View
None Diabete Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None coronary artery disease View
None diabetes mellitus View
None percutaneous coronary intervention View
None SGLT-2 inhibitor View
None insulin resistance View
None platelet reactivity View